PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2D322F579D4558649412!levofloxacin solution for INJ. 750mg — Akorn, Inc

PoP ended Oct 5, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support

Awarding office

Akorn, Inc

Recipient

Oct 5, 2022

PoP end

$166K

Obligated

$166K

Potential

325411

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract numberSPE2D322F579D

Also listed asSPE2D020D0011-SPE2D322F579D

AgencyDla Troop Support

Awarding officeDla Troop Support

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentAkorn, Inc

CAGE55751

UEIN59RE1KDGAZ5

NAICS325411

No full NAICS 325411 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVSPE2D020D0011

Place of performanceLAKE FOREST IL

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startSep 30, 2022

PoP end (current)Oct 5, 2022

Obligated$166K

Current value$166K

Potential value$166K

4558649412!LEVOFLOXACIN SOLUTION FOR INJ., 750MG/30 is a federal award for Dla Troop Support held by Akorn, Inc. Estimated value $166K ($166K obligated). Current period of performance ends Oct 5, 2022. Place of performance: LAKE FOREST IL.

4558649412!LEVOFLOXACIN SOLUTION FOR INJ., 750MG/30

Recompete timing

Public

● Past PoP end (1456 days ago)

Current PoP ended Oct 5, 2022 (1456 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on SPE2D322F579D? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract SPE2D322F579D?

SPE2D322F579D (4558649412!levofloxacin solution for INJ. 750mg) is a Dla Troop Support award with a potential value of $166K, currently held by Akorn, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2D322F579D?

Dla Troop Support awarded SPE2D322F579D to Akorn, Inc (potential $166K).

Who is the incumbent on SPE2D322F579D?

Akorn, Inc is the incumbent. The current period of performance ends Oct 5, 2022.

When does Akorn, Inc’s SPE2D322F579D come up for recompete?

SCOUT tracks a period-of-performance end of Oct 5, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on SPE2D322F579D? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Sep 30, 2022 · refreshed monthly